A Child with Chronic Mucocutaneous Candidiasis Harbors a Novel Gain-of-Function Mutation in STAT1
Journal of Clinical Immunology · Published 2025-12-01 · Available online 30 Sep 2025 · Journal article · DOI 10.1007/s10875-025-01937-4 · Cited by 2 (Crossref)
Free full text
Authors (11)
Yang Xiang, Shuo Sun, Hong Wang, Chia‑Chi Lo, Jie Wu, Wei‑Te Lei, Fengming Li, Xiaodong Liu, Ningning Dang, Cheng-Lung Ku, Jing Guo
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Volume
- 45
- Issue
- 1
- Year
- 2025
Citation
Xiang, Y., Sun, S., Wang, H., et al. (2025). A Child with Chronic Mucocutaneous Candidiasis Harbors a Novel Gain-of-Function Mutation in STAT1. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-025-01937-4
Related articles
- Evolution of Inborn Errors of Immunity in China: Discoveries and Treatment Paradigms · Clinical Reviews in Allergy and Immunology · 2026 · Cites or is cited by this article
- Genetic Diagnosis and Identification of a Novel De Novo RELA Variant in Familial Behçet-like Autoinflammatory Syndrome Type 3: A Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy · Journal of Clinical Immunology · 2026 · Same journal
- Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation · Journal of Clinical Immunology · 2026 · Same journal
- Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Humoral Immune Abnormalities in Transient Childhood Neutropenia: Insights From a 10-year Cohort Study in a Tertiary Center · Journal of Clinical Immunology · 2026 · Same journal
- Phenotypic Heterogeneity in CD40 Ligand Deficiency: Long-term Follow-up of a Patient with the c.156G > A Splice Variant · Journal of Clinical Immunology · 2026 · Same journal
- First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults · Journal of Clinical Immunology · 2026 · Same journal
- Antigen Microarray Reveals Broad and Subclinical Autoimmunity in Patients with Inborn Errors of Immunity · Journal of Clinical Immunology · 2026 · Same journal
- Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome · Journal of Clinical Immunology · 2026 · Same journal
Metrics
- Citations (Crossref)
- 2